PhuturdexDrug Pipeline Intelligence

Phuturdex › Diseases › Hot flash

Drugs in development · updated 30 October 2026

Hot flash: drugs in development

As of 30 October 2026 there are 10 active clinical trials (recruiting or ongoing, phases I–III) on 8 drugs for hot flash. One is experimental, that is not yet approved in the United States.

10Active trials
1Experimental drugs
0Experimental, in phase III

Summary updated every week · data as of 30 October 2026. In Phuturdex you get the full detail of every drug and an email when an alert is published on the ones you follow.

Sign in free →

Experimental drugs

Not yet approved by the US FDA for any indication.

DrugMost advanced phaseActive trialsReference trial
AsimadolineII1NCT07042516

Sorted by most advanced phase and number of active trials.

Approved drugs in new trials

Approved by the US FDA for at least one indication, not necessarily this disease, and now in active trials on it.

DrugMost advanced phaseActive trialsReference trial
FezolinetantVeozah®, Veoza®III5NCT06440967
ElinzanetantLynkuet®III2NCT05587296
TamoxifenSoltamox®, Nolvadex®III1NCT06440967
BazedoxifeneConbriza®, Brilence®II1NCT04821141
ClonidineQlonilik®, Javadin®II1NCT01530373
Conjugated EstrogensII1NCT04821141
SolifenacinVesicare Ls®, Vesicare®II1NCT01530373

Sorted by most advanced phase and number of active trials.

All 8 drugs, with the details

In Phuturdex every drug has all its trials, sponsors and countries, FDA and EMA approvals, orphan designations and safety alerts. Free until 31 March 2027.

Open in Phuturdex →

Broader categories

Source: Phuturdex analysis of ClinicalTrials.gov data (U.S. National Library of Medicine), updated 30 October 2026. Active trials = recruiting or ongoing, phases I–III, with at least one identified drug; phase and sites refer to the trials on this disease. Disease name: Wikidata; NLM MeSH term: D019584 “Hot Flashes”.

ItalianoFrançaisDeutsch